Physician profile
Benjamin Lindbloom
NPI 1699065128
$67,334.70
in general payments reported to CMS, 2019-2025
29 companies · $3,631 in 2025
The $3,631 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,621 · 2020: $2,914 · 2021: $6,573 · 2022: $12K · 2023: $15K · 2024: $22K · 2025: $3,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Travel and Lodging: $10K · Food and Beverage: $4,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,727.50 |
| Travel and Lodging | $10,217.25 |
| Food and Beverage | $4,119.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $20,308.29 | 2022-2024 | Inset System |
| Arthrex, INC. | $15,730.32 | 2020-2022 | |
| Medical Device Business Services, INC. | $10,948.31 | 2023 | Inhance |
| Smith+Nephew, INC. | $7,002.18 | 2019-2025 | Acufex Meniscal Root Repair, Healicoil, Q-Fix |
| Encore Medical, LP | $5,882.29 | 2019-2025 | Djo Surgical |
| Reel Surgical, INC. | $2,670.93 | 2021-2024 | |
| Acumed LLC | $1,573.17 | 2023 | Acumed, Innate Implant |
| Stryker Corporation | $803.05 | 2019-2025 | Tornier Perform Anatomic Augmented Glenoid, Aequalis Flex Revive, Augment Injectable |
| Depuy Synthes Sales INC. | $722.20 | 2019-2023 | Inhance, Velys |
| Arthrosurface Incorporated | $705.29 | 2019 | |
| Horizon Therapeutics Plc | $469.47 | 2019-2021 | |
| Heron Therapeutics, INC. | $72.99 | 2022 | |
| Bioventus LLC | $71.35 | 2019-2025 | Xcell |
| Zyla Life Sciences, INC. | $54.39 | 2019 | |
| Orthofix Medical, INC. | $49.50 | 2021-2025 | Physio-Stim |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $28.82 | 2021 | |
| Zimmer Biomet Holdings, INC. | $28.25 | 2019-2022 | |
| Acell, INC. | $25.11 | 2019 | |
| Next Science LLC | $23.27 | 2022 | |
| Solventum Corporation | $21.49 | 2025 | Activ.A.C. |
| Heraeus Medical, LLC. | $19.77 | 2022 | |
| Medtronic, INC. | $18.33 | 2024 | V-Loc 180 |
| Guard Medical INC. | $17.17 | 2024 | Npseal Large |
| Linvatec Corporation | $17.15 | 2024 | Biobrace 23mm |
| Ethicon US, LLC | $15.60 | 2022 | |
| Pacira Therapeutics, INC. | $15.14 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.19 | 2022 | |
| Wright Medical Technology, INC. | $13.97 | 2019 | |
| Ermi LLC | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lindbloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.